The Latest Articles from Streetwise Reports


Sales of Antibiotic Alternative for Livestock Feed Accelerate in Asia

  ()
With antibiotic resistance a major health issue, the search is on for effective alternatives to replace antibiotics in livestock feed to promote growth. read more >

Plus Therapeutics Shares Trade Higher on Q3 Earnings and Business Restructuring

  ()
Plus Therapeutics shares traded higher after the firm reported Q3/19 financial and business results. In the most recent quarter, the company completed the change of its name, relocated its headquarters to Austin, and raised $15 million for R&D and working capital. read more >

Exicure's Collaboration with Allergan on Treating Hair Loss Disorders Sends Shares Higher

  ()
Shares of Exicure Inc. opened 30% higher after the firm reported that it entered into a collaboration agreement with Allergan to discover and develop SNA-based treatments for hair loss disorders. The terms of the deal provide for a $25 million upfront payment to Exicure with the potential to grow to $750 million. read more >
News Update

Clinical Trial Results for Alcoholic Hepatitis Drug Delivered in Webcast

News Update
  ()
The online presentation coincides with The Liver Meeting 2019, at which data also are shared. read more >

FDA Approval of Peanut Allergy Treatment Expected Next Year

Research Report
  ()
The current status, catalysts and outlook for the immunotherapy are discussed in a ROTH Capital Partners report. read more >
News Update

Biopharma Presents Data on Alcoholic Hepatitis Therapeutic at Liver Meeting

News Update
  ()
The company intends to follow up in 2020 with a Phase 2b clinical trial. read more >

Electromed Earnings Spark a 25% Increase in Its Share Price

  ()
Shares of SmartVest maker Electromed traded 25% higher after the firm reported Q1/20 earnings. The firm's shares set a 52-week high price after reporting a 14.1% increase in year-over-year quarterly revenue and a six-fold increase in net income per share. read more >

Seachange in Mexico on Cannabis Could Benefit This Small Cap

Contributed Opinion
  ()
Technical analyst Clive Maund highlights a small-cap that may be poised to benefit from the recent Mexican Supreme Court decision on cannabis. read more >

Reliq Re-establishes Itself as Community Care Technology Leader Amidst Sweeping Federal Medicare/Medicaid Changes

Contributed Opinion
  ()
A shift in the industry leads to big new contracts and parabolic stock performance for this small cap. read more >

Imagin Medical Poised for Breakout with Bladder Cancer Detection Device in FDA Approval Process

Contributed Opinion
  ()
A new advancement in bladder-related endoscopic surgery is endorsed and de-risked. read more >

Castle Biosciences Shares Storm Higher After Quadrupling Q3 YoY Revenue

  ()
Shares of melanoma and other skin cancers diagnostic firm Castle Biosciences Inc. traded more than 15% higher after the firm announced Q3/19 financial and operational results. read more >

Iovance Biotherapeutics Shares Rise 12% on Updated Phase 2 Melanoma Study Results

  ()
Shares of Iovance Biotherapeutics traded 12% higher after the firm reported updated clinical data from its phase 2 lifileucel metastatic melanoma trial. read more >

Dexcom Posts 49% YoY Revenue Growth, Sending Shares to 52-Week High

  ()
Glucose monitoring systems developer Dexcom's shares traded 30% higher after releasing Q3/19 earnings and raising full-year 2019 guidance. read more >

Could There Finally Be an Effective Treatment for Alzheimer's Disease?

  ()
ProMIS' preclinical treatment could possibly outshine Biogen's candidate. read more >

Aquestive Therapeutics Shares Up on Pipeline Update and Raised Full-Year 2019 Guidance

  ()
Aquestive Therapeutics Inc. shares traded 20% higher after the firm reported Q3/19 earnings and raised its FY/19 guidance. The firm states it expects to complete its NDA for Libervant buccal film near the end of this month. read more >

Fulgent Genetics Hits 52-Week High After Posting 84% Q3 Revenue Increase

  ()
Fulgent Genetics shares traded more than 40% higher after the company reported record revenue in Q3/19. The firm noted that it completed a record 20,697 billable tests in the quarter, up 272% over the same period last year. read more >

RedHill Biopharma Shares Rise 10% After Receiving FDA Approval for H. Pylori Treatment Drug Talicia

  ()
Shares of RedHill Biopharma Ltd. traded higher after the firm announced that the FDA has approved its Talicia delayed-release capsules for the treatment of H. pylori infection in adults. The firm plans to commence distribution by its U.S. sales force in Q1/20. read more >
News Update

Vancouver Firm Receives Cannabis Flower Sales License, First Order

News Update
  ()
Both of these events are significant achievements for the company. read more >
News Update

Canadian Tech Firm Lands U.S. Medical Case Management Firm as Client

News Update
  ()
This new partner seeks to employ the company's telemedicine/mobile health system. read more >

BeiGene Shares Up 35% on Amgen's $2.7 Billion Investment and China Partnership

  ()
Shares of BeiGene Ltd. traded 35% higher to a new a 52-week intraday high after announcing a commercialization agreement for of XGEVA (denosumab), KYPROLIS (carfilzomib), and BLINCYTO (blinatumomab) with Amgen Inc. in China. As part of the partnership, Amgen will invest $2.7 billion in BeiGene for 20.5% equity ownership. read more >
News Update

Tech Firm Partners With Pharmacy, Diabetes Management Entities

News Update
  ()
The Canadian company will provide its remote patient monitoring and chronic care management software solutions to these two U.S. enterprises. read more >

Navidea Shares Jump 60% on Phase 2b Rheumatoid Arthritis Trial Results

  ()
Shares of Navidea Biopharmaceuticals traded greatly higher on extremely high relative volume after the firm released data from its Phase 2b Rheumatoid Arthritis Tc 99m Tilmanocept Planar Imaging study. read more >

New Data Could Drive Use of Pancreatic Cancer Early Detection Test

Research Report
  ()
The recent results and their implications are provided in an H.C. Wainwright & Co. report. read more >
News Update

Tech Firm Releases Telemedicine Product Aiding Senior Care, Safety

News Update
  ()
The package encompasses wearable devices, two-way video communication and geofencing. read more >

IVERIC bio Shares Double After Announcing Phase 2b AMD Topline Data

  ()
Shares of IVERIC bio traded 100% higher after reporting that it successfully met its primary endpoint in its Phase 2b age-related macular degeneration study for Zimura. read more >
Showing Results: 1 to 25 of 177 Next

Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts

"DRRX's psoriasis trial is on target for topline data by year-end 2019." ❭
– Ed Arce, H.C. Wainwright & Co.